Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
ADMETRx
ADMETRx & Roche Collaborate on Multicriteria Decision-Making Application
December 5th, 2008
ADMETRx, a Contract Research group committed to providing the best in vitro ADME discovery support possible, has initiated a collaboration with Roche to advance the development of ADMETRx proprietary multi-criteria decision-making models applied to drug discovery. ADMETRx and Roche both recognize how comprehensive data integration may offer significant advantages to discovery groups in selecting candidates for advancement. ADMETRx CEO and Chief Scientific Officer Phil Burton, PhD, said, "Effectively using all the data available in a discovery program to prioritize or advance candidates with the best development potential is a significant challenge in the pharmaceutical...
Source: Health Business Week (2008-12-05)
|
